Mangoceuticals MGRX
NASDAQ MGRX
$0.44 -0.04 (-9.03%)
At close: Oct 2, 2026 · 4:00 PM EDT

Mangoceuticals (MGRX) Price to Sales (2023 - 2026)

Updated

Mangoceuticals' (MGRX) Price to Sales was 21.72 for Q2 2026, down 30.7% from 31.35 a year earlier but up 47.4% from the prior quarter.

Analysis

Mangoceuticals (MGRX) Price to Sales (2023 - 2026) Analysis & Trends

For FY2025, Price to Sales at Mangoceuticals was 16.34, up 110.2% from FY2024.

  • By year, Price to Sales came in at 7.78 in FY2024 (+27.3%) and 6.11 in FY2023.
  • Five-year quarterly Price to Sales spans a low of 6.08 in Q1 2024 and a high of 54.05 in Q3 2025.
  • Year over year, Price to Sales gained in five of the last seven quarters, with growth averaging 132.3%.
  • Per Business Quant data, the three quarters before Q2 2026 came in at 14.73 (Q1 2026), 16.34 (Q4 2025) and 54.05 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 HCA Healthcare 92.33 Bn 91.77 Bn -
2 Natera 58.66 Bn 54.34 Bn 485.19 Mn
3 Quest Diagnostics 25.51 Bn 23.94 Bn 1.03 Bn
4 Labcorp Holdings 24.64 Bn 22.41 Bn 1.11 Bn
5 Guardant Health 23.35 Bn 19.41 Bn 219.03 Mn
6 Tenet Healthcare 20.47 Bn 11.62 Bn -
7 Tempus AI 13.40 Bn 10.43 Bn 246.50 Mn
8 Encompass Health 11.75 Bn 12.21 Bn -
9 BrightSpring Health Services 11.31 Bn 9.65 Bn 492.75 Mn
10 Mangoceuticals 8.65 Mn 6.28 Mn 44,215.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 21.72
Mar 31, 2026 14.73
Dec 31, 2025 16.34
Sep 30, 2025 54.05
Jun 30, 2025 31.35
Mar 31, 2025 17.52
Dec 31, 2024 7.78
Sep 30, 2024 10.01
Jun 30, 2024 10.22
Mar 31, 2024 6.08
Dec 31, 2023 6.11
API Access

Mangoceuticals Price to Sales API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-sales&ticker=MGRX&period=max&api_key=YOUR_API_KEY